Evotec AG (NASDAQ:EVTCY) | WebDisclosure

Basculer en Français

9480	Companies
185531	Keywords
117925	Articles
99377	Press releases

Home
Companies
Evotec AG

BRIEF

published on 12/04/2025 at 08:35, 1 day 11 hours ago

Bayer lance une étude de phase 2 pour le traitement du syndrome d'Alport avec Evotec

Bayer Essai Clinique Evotec Syndrome D'Alport Sémaphorine-3A
BRIEF

published on 12/04/2025 at 08:35, 1 day 11 hours ago

Bayer Initiates Phase 2 Study for Alport Syndrome Treatment with Evotec

Clinical Trial Bayer Evotec Alport Syndrome Semaphorin-3A
PRESS RELEASE

published on 12/04/2025 at 08:30, 1 day 11 hours ago

Evotec-partner Bayer starts Phase 2 study for treatment of patients with Alport syndrome
Evotec-partner Bayer initiates Phase 2 study for potential Alport syndrome treatment. BAY 3401016 mAb targets Sema3A protein

Bayer Evotec Phase 2 Study Alport Syndrome BAY 3401016
BRIEF

published on 11/12/2025 at 07:35, 23 days 12 hours ago

Evotec obtient un paiement d'étape de Bristol Myers Squibb

Evotec Approbation De La FDA Paiement D'étape Bristol Myers Squibb Dégradation Des Protéines
BRIEF

published on 11/12/2025 at 07:35, 23 days 12 hours ago

Evotec Secures Milestone Payment from Bristol Myers Squibb

FDA Approval Evotec Milestone Payment Bristol Myers Squibb Protein Degradation
PRESS RELEASE

published on 11/12/2025 at 07:30, 23 days 12 hours ago

Evotec receives milestone payment from Bristol Myers Squibb following IND acceptance in strategic protein degradation partnership
Evotec receives US$ 5m milestone payment from Bristol Myers Squibb for IND acceptance in protein degradation partnership, advancing drug candidate towards Phase 1 clinical trial

Evotec Milestone Payment Bristol Myers Squibb Protein Degradation IND Acceptance
BRIEF

published on 11/05/2025 at 07:35, 1 month ago

Evotec SE Reports Resilient 9M 2025 Results with Strategic Focus

Strategic Alliances Evotec SE Biologics Growth 9M 2025 Results Sandoz Transaction
BRIEF

published on 11/05/2025 at 07:35, 1 month ago

Evotec SE annonce des résultats solides pour les 9 premiers mois de l'année 2025, avec une orientation stratégique.

Evotec SE Croissance Des Produits Biologiques Alliances Stratégiques Résultats 9M 2025 Transaction Sandoz
PRESS RELEASE

published on 11/05/2025 at 07:30, 1 month ago

Evotec SE reports 9M 2025 results: Continued strong execution on strategic priorities
Evotec SE reports 9M 2025 results with €535.1m group revenues, strong scientific advancements, landmark industry transaction, and confirmed 2025 guidance and 2028 outlook

Strategic Priorities Evotec SE 9M Results 2028 Outlook Landmark Industry Transaction
BRIEF

published on 11/04/2025 at 22:10, 1 month ago

Evotec Signs Milestone Agreement with Sandoz, Eyes Substantial Revenue

Pharmaceutical Industry Biosimilars Evotec Manufacturing Technology Sandoz

Accesswire

Published on 12/05/2025 at 19:20, 24 minutes ago

The Multi-Sector Validation Shock: Why SMX Became Impossible for Markets to Ignore
Published on 12/05/2025 at 18:45, 59 minutes ago

Four Global Markets, One Engine: SMX Just Redefined What a Supply Chain Can Prove
Published on 12/05/2025 at 18:20, 1 hour 24 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 1 hour 44 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 2 hours 29 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:58, 46 minutes ago

EQS-Adhoc: HORNBACH Holding AG & Co. KGaA: Reduced earnings in Q3 2025/26 – Guidance for adjusted EBIT at previous year’s level still valid
Published on 12/05/2025 at 18:26, 1 hour 18 minutes ago

POS-Transaction in Own Shares
Published on 12/05/2025 at 18:15, 1 hour 29 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 1 hour 52 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 1 hour 58 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds

Les Echos

Published on 12/05/2025 at 17:18, 2 hours 26 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 2 hours 26 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 4 hours 33 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 4 hours 33 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 5 hours 46 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE